GELS logo

GELTEQ LTD

GELSNASDAQ
🏆 #5218 by market capUS Equity
$0.53▼ $0.01 (−2.05%)
After hours · at close
🔔
Track GELS
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 2.0%
7d▼ 9.4%
14d▼ 13.8%
30d▼ 6.2%
ytd▼ 33.7%
1y▼ 60.7%
🏦Market Cap
$6M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
84
Good

Trading Snapshot

Day Range
$0.53 – $0.54
52-Week Range
—
Volume
$3.18B
Avg Volume
$2.51B
Shares Outstanding
10.7M
Next Earnings
Nov 17, 2026

Fundamentals Snapshot

Annual Revenue
$165,645
Last Q Revenue
$89,296
P/E Ratio
—
P/S Ratio
—
EPS (TTM)
—
Dividend Yield
—
Dilution (1yr)
+0.0%

Why Investors Own GELS

  • ✓High-growth profile — revenue up +54.8% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 49% gross margin and 26% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

GELS logo

GELTEQ LTD

GELS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$166K▲ +0.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
100.0%▲ +158.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$5M▲ +86.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$6M▲ +405.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
10.5M▲ +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$5M▼ −$4M YoY
StockOtter · stockotter.space

About GELTEQ LTD

Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
84/100

Analyst Price Target

ⓘ
Average Target
$0.58
▲ +8.5% Upside
High Target$0.66
Low Target$0.45
Based on 37 analysts

Latest News & Updates

🚀
CNBC·2h ago

GELTEQ LTD tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift GELS price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

GELTEQ LTD announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.